Literature DB >> 22408173

Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Robyn Balden1, Amutha Selvamani, Farida Sohrabji.   

Abstract

Vitamin D deficiency (VDD) is widespread and considered a risk factor for cardiovascular disease and stroke. Low vitamin D levels are predictive for stroke and more fatal strokes in humans, whereas vitamin D supplements are associated with decreased risk of all-cause mortality. Because VDD occurs with other comorbid conditions that are also independent risk factors for stroke, this study examined the specific effect of VDD on stroke severity in rats. Adult female rats were fed control or VDD diet for 8 wk and were subject to middle cerebral artery occlusion thereafter. The VDD diet reduced circulating vitamin D levels to one fifth (22%) of that observed in rats fed control chow. Cortical and striatal infarct volumes in animals fed VDD diet were significantly larger, and sensorimotor behavioral testing indicated that VDD animals had more severe poststroke behavioral impairment than controls. VDD animals were also found to have significantly lower levels of the neuroprotective hormone IGF-I in plasma and the ischemic hemisphere. Cytokine analysis indicated that VDD significantly reduced IL-1α, IL-1β, IL-2, IL-4, IFN-γ, and IL-10 expression in ischemic brain tissue. However, ischemia-induced IL-6 up-regulation was significantly higher in VDD animals. In a separate experiment, the therapeutic potential of acute vitamin D treatments was evaluated, where animals received vitamin D injections 4 h after stroke and every 24 h thereafter. Acute vitamin D treatment did not improve infarct volume or behavioral performance. Our data indicate that VDD exacerbates stroke severity, involving both a dysregulation of the inflammatory response as well as suppression of known neuroprotectants such as IGF-I.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22408173      PMCID: PMC3339639          DOI: 10.1210/en.2011-1783

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  125 in total

Review 1.  Insulin-like growth factor-1 as a vascular protective factor.

Authors:  Elena Conti; Cinzia Carrozza; Ettore Capoluongo; Massimo Volpe; Filippo Crea; Cecilia Zuppi; Felicita Andreotti
Journal:  Circulation       Date:  2004-10-12       Impact factor: 29.690

Review 2.  The role of insulin-like growth factor I components in the regulation of vitamin D.

Authors:  José Manuel Gómez
Journal:  Curr Pharm Biotechnol       Date:  2006-04       Impact factor: 2.837

3.  Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury.

Authors:  S Schwab; M Spranger; S Krempien; W Hacke; M Bettendorf
Journal:  Stroke       Date:  1997-09       Impact factor: 7.914

Review 4.  Vitamin D and vascular calcification.

Authors:  Armin Zittermann; Stefanie S Schleithoff; Reiner Koerfer
Journal:  Curr Opin Lipidol       Date:  2007-02       Impact factor: 4.776

Review 5.  Interactions of 1,25-dihydroxyvitamin D3 and the immune system.

Authors:  S C Manolagas; D M Provvedini; C D Tsoukas
Journal:  Mol Cell Endocrinol       Date:  1985-12       Impact factor: 4.102

Review 6.  Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

Authors:  Margherita T Cantorna; Brett D Mahon
Journal:  Exp Biol Med (Maywood)       Date:  2004-12

7.  The relationship between inflammatory markers and post stroke cognitive impairment.

Authors:  Lana S Rothenburg; Nathan Herrmann; Walter Swardfager; Sandra E Black; Gayla Tennen; Alexander Kiss; David J Gladstone; Jon Ween; Abraham Snaiderman; Krista L Lanctôt
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-07-02       Impact factor: 2.680

8.  Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain.

Authors:  D Eyles; L Almeras; P Benech; A Patatian; A Mackay-Sim; J McGrath; F Féron
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12-23       Impact factor: 4.292

9.  Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults.

Authors:  R Scragg; K T Khaw; S Murphy
Journal:  Eur J Clin Nutr       Date:  1995-09       Impact factor: 4.016

10.  Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis.

Authors:  Jessica A Alvarez; Ambika Ashraf
Journal:  Int J Endocrinol       Date:  2010       Impact factor: 3.257

View more
  52 in total

Review 1.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

2.  Vitamin D for the prevention of stroke incidence and disability: promising but too early for prime time.

Authors:  E D Michos; R F Gottesman
Journal:  Eur J Neurol       Date:  2012-07-11       Impact factor: 6.089

3.  Association of Serum 25(OH) D Levels with Infarct Volumes and Stroke Severity in Acute Ischemic Stroke.

Authors:  Y Y Li; Y-S Wang; Y Chen; Y H Hu; W Cui; X Y Shi; W Jiang; J M Zhang
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats.

Authors:  Caitlin S Latimer; Lawrence D Brewer; James L Searcy; Kuey-Chu Chen; Jelena Popović; Susan D Kraner; Olivier Thibault; Eric M Blalock; Philip W Landfield; Nada M Porter
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

5.  Mir363-3p improves ischemic stroke outcomes in female but not male rats.

Authors:  Amutha Selvamani; Farida Sohrabji
Journal:  Neurochem Int       Date:  2016-10-20       Impact factor: 3.921

6.  Vitamin D deficiency is associated with acute ischemic stroke, C-reactive protein, and short-term outcome.

Authors:  Daniela Frizon Alfieri; Márcio Francisco Lehmann; Sayonara Rangel Oliveira; Tamires Flauzino; Francieli Delongui; Maria Caroline Martins de Araújo; Isaias Dichi; Vinícius Daher Delfino; Leda Mezzaroba; Andréa Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Metab Brain Dis       Date:  2016-12-14       Impact factor: 3.584

7.  Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia.

Authors:  Serafí Cambray; Manuel Portero-Otin; Mariona Jové; Nuria Torreguitart; Laura Colàs-Campàs; Arabela Sanz; Ikram Benabdelhak; Muge Yemisci; Turgay Dalkara; Buket Dönmez-Demir; Joaquim Egea; Francisco Purroy
Journal:  Mol Neurobiol       Date:  2017-12-21       Impact factor: 5.590

8.  Fetal Alcohol Exposure Alters Blood Flow and Neurological Responses to Transient Cerebral Ischemia in Adult Mice.

Authors:  Shameena Bake; Rachel Gardner; Joseph D Tingling; Rajesh C Miranda; Farida Sohrabji
Journal:  Alcohol Clin Exp Res       Date:  2016-12-17       Impact factor: 3.455

9.  The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Authors:  Marie-France Nissou; Jacques Brocard; Michèle El Atifi; Audrey Guttin; Annie Andrieux; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection.

Authors:  Fahim Atif; Seema Yousuf; Iqbal Sayeed; Tauheed Ishrat; Fang Hua; Donald G Stein
Journal:  Neuropharmacology       Date:  2012-11-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.